Clinical TrialID 6922
Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne
NCT03832647
Acne
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6922
- Evidence Id
- 6922
- Core Evidence Id
- 6922
- Source Clinical Trial Id
- 6914
- Herb2 Clinical Trial Id
- HBCT006914
- Nct Id
- NCT03832647
- Title
- Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Acne
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- COMBINATION_PRODUCT: Epiduo|DRUG: Salicylic Acid|OTHER: Hydréane légère
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult
- Enrollment
- 200
- Outcome Measure
- Evaluation of the anti-acne efficacy 1 (number of the retentional and inflammatory lesions), Change in the number of the retentional (open \& closed comedones) and inflammatory lesions (papulae, pustulae \& nodules (if applicable)) on face after a 12-week application period At Week 0 (before any application) and Week 12 (after a 12-week application period), a counting of the retentional (open \& closed comedones) and inflammatory lesions (papulae, pustulae \& nodules (if applicable)) will be performed by a Dermatologist. The counting will be broken down on several parts of the face (forehead, left and right cheeks and chin)., Week 0 (baseline) and Week 12 (final time point)
- Sponsor Collaborator
- Vichy Laboratoires
- Funded By
- INDUSTRY
- Location
- INTERTEK, Paris, 75013, France
- Other Id
- VCA 18-01|2018-A02481-54
- Start Date
- 2019-02-18
- Primary Completion Date
- 2020-02-17
- Completion Date
- 2020-02-17
- First Posted
- 2019-02-06
- Results First Posted
- Last Update Posted
- 2021-10-18
- Study Document
- Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/47/NCT03832647/Prot_SAP_000.pdf
- Study Url
- https://clinicaltrials.gov/study/NCT03832647
- Title Cn
- Title En
- Anti-acne Efficacy of a Dermo-cosmetic Product Associated With the Fixed Combination Adapalene 0.1%/ Benzoyl Peroxide 2.5% Treatment Versus This Treatment Associated With a Standard Moisturizer in Male and Female Subjects Presenting With Mild to Moderate Acne
- Bilingual Status
- semi_complete